Intellia Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Intellia Therapeutics, Inc. (NTLA) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.190.230.520.120.160.280.31
Short-Term Investments0.410.690.670.630.440.000.00
Cash & Short-Term Investments0.600.911.190.750.600.280.31
Accounts Receivable0.010.040.000.000.000.000.01
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.030.050.020.020.010.000.00
Total Current Assets0.641.001.220.770.620.290.32
Non-Current Assets
Property, Plant & Equipment (Net)0.250.150.160.100.060.040.02
Long-Term Investments0.290.140.130.420.000.000.00
Other Non-Current Assets0.020.020.020.000.000.000.01
Total Non-Current Assets0.550.300.300.530.060.040.02
Total Assets1.191.301.521.290.680.330.35
Current Liabilities
Accounts Payable0.010.010.010.010.010.020.01
Short-Term Debt0.020.000.000.000.000.000.00
Accrued Liabilities0.060.060.060.040.030.000.00
Deferred Revenue0.020.020.040.060.020.000.00
Other Current Liabilities0.060.010.020.020.010.010.00
Total Current Liabilities0.110.120.130.130.060.040.04
Non-Current Liabilities
Long-Term Debt0.190.100.110.060.030.010.00
Other Non-Current Liabilities0.000.060.020.130.070.030.00
Total Non-Current Liabilities0.210.140.160.130.080.030.03
Total Liabilities0.320.250.280.250.150.060.07
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-2.18-1.66-1.18-0.70-0.44-0.30-0.20
Accumulated Other Comprehensive Income0.000.00-0.010.000.000.000.00
Additional Paid-in Capital3.052.712.421.750.960.570.48
Shares Outstanding0.100.090.090.070.000.000.00
Total Stockholders' Equity0.871.051.241.040.530.270.28
Total Liabilities & Equity1.191.301.521.290.680.330.35